Cancer drugs to get cheaper? Here’s what the latest government order says

Search+

ET Online | 22 Oct 2026, 02:34 PM ISTThe government has capped trade margins on 137 anti-cancer drugs at 30%, with the revised prices set to take effect from November 9, 2026. How will the new pricing formula work, which medicines are covered, and what rules apply to hospital supplies and free patient-assistance programmes? We explain the new rules, the potential price reductions and whether patients can expect to pay less for cancer medicines. Show more Show lessRead more oncancer medicinecancer treatment medicinecancer treatmentcancer medicine pricecancer medicine price listanti cancer medicineblood cancer medicinebreast cancer medicinenew cancer medicineNPPA

Related Videos
• 04:13Cancer drugs to get cheaper? Here’s what the latest government order saysViews: 182
• 34:38AI in Pharma: How India's Drug Giants Are Betting Big on Artificial IntelligenceViews: 35975
• 01:37The brutal leadership lesson that shaped Dr. Reddy’s chiefViews: 1279
• 32:25We are discovery rich, but development poorViews: 1179
• 02:07Budget 2026: India’s pharma leap, BioPharma SHAKTI gets ₹10K cr; 1,000 clinical trial sites plannedViews: 435
• 34:23Corner Office Conversation: Nandini Piramal of Piramal Pharma & Arjun Juneja of Mankind PharmaViews: 575
• 31:08Apollo’s Suneeta Reddy and Dr Preetha Reddy on the Next 10 Years of HealthcareViews: 496
• 33:30Corner Office Conversation with The New Leaders of Indian PharmaViews: 1454
• 04:16Covishield row: AstraZeneca reaffirms vaccine safety amidst rare 'side effect' concernsViews: 956
• 04:44DRL at 40: Corner office conversation with Co-Chairman & MD, G.V. PrasadViews: 690
• 01:00Painkiller Meftal can have adverse reactions, govt issues alertViews: 3579
• 01:33WHO recommends 2nd Malaria vaccine R21/Matrix-M made by Oxford-Serum Institute; says cheap, more effectiveViews: 697
• 02:15Govt caps prices of 51 crucial medicines used for ear, throat, heart & sugar-related illnessesViews: 1438
• 00:33Government bans 14 fixed-dose combination drugs, says 'no therapeutic justification'Views: 15296
• 01:44Fosun Pharma withdraws plan to sell equity holding in Gland Pharma: SourcesViews: 3178
• 02:05Drug licences of 18 pharma firms cancelled for manufacturing spurious medicines: DCGIViews: 20662
• 02:13Prices of painkillers, antibiotics, anti-infectives and cardiac drugs set to increase from AprilViews: 3814
• 02:41DCGI sends a show-cause notice to e-pharmacies for selling drugs without licenceViews: 1467
• 01:52Covid Nasal Vaccine: India's first intranasal vaccine 'iNCOVACC' to be launched on Republic Day 2023Views: 1420
• 01:05Covid-19: DCGI approves market authorisation for Covovax as heterologous booster doseViews: 783
• 02:29Cough syrup linked deaths: Health Minister takes note of Uzbekistan's claims; facility inspectedViews: 831
• 02:35Nasal COVID vaccine makes debut, now available on CoWin; dose price yet to be announcedViews: 1453
• 02:55Four India-made cough syrups under the scanner; CDSCO initiates probe after WHO red-flagsViews: 2003
• 02:53Cervical cancer: India's first indigenously developed vaccine to be launched todayViews: 1580
• 01:10Biological E to invest Rs 1800 crore in HyderabadViews: 943
• 01:14COVID-19: Bharat Biotech's nasal vaccine phase III trials completed, informs Dr Krishna EllaViews: 1677
• 02:14Indian Govt panel approves country's first indigenous vaccine for cervical cancer for aged 9-26 yearsViews: 1565
• 04:05NPPA hikes prices of 800 essential drugs by 11%Views: 2119
• 02:08COVID vaccine: DCGI grants restricted EUA for Biological E's 'Corbevax' for 12-18 yrs age groupViews: 1124
• 01:31Drug regulator grants emergency use permission to single-dose Sputnik Light Covid vaccineViews: 785
• 01:23Bharat Biotech's nasal Covid-19 booster gets nod for trial in IndiaViews: 1808
• 02:45Is Molnupiravir harmful? ICMR chief explainsViews: 13537
• 01:49Tata's COVID Test Kit 'OmiSure' to detect Omicron variant gets ICMR nod; priced at Rs 250Views: 35889
• 01:55Drug regulator CDSCO approves Corbevax, Covovax, Molnupiravir for restricted emergency use against Covid-19Views: 1619
• 00:25Bharat Biotech seeks DCGI nod for phase-3 trials of intranasal COVID vaccine as booster doseViews: 1422
• 09:06Covaxin more effective against Omicron, as per scientific conjecture: Head of Epidemiology, ICMRViews: 166
• 01:00Pfizer: covid-19 antiviral pill cut rates of hospitalisation, death risk by 89%, says DR. Mikael DolstenViews: 1237
• 01:00Covid experimental pill cuts hospital, death risk by 90%: PfizerViews: 1076
• 01:03Momentous occasion for Indian science: Bharat Biotech MD after WHO grants EUL to CovaxinViews: 496
• 03:28Covaxin gets WHO approval for emergency useViews: 1263